Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort study.
about
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical useCurrent methods for the reduction of blood-borne pathogens: a comprehensive literature reviewMain Properties of the THERAFLEX MB-Plasma System for Pathogen ReductionPlasma components: properties, differences, and uses.Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.Type of plasma preparation used for plasma exchange and clinical outcome of adult patients with acquired idiopathic thrombotic thrombocytopenic purpura: a French retrospective multicenter cohort study.Storage of thawed plasma for a liquid plasma bank: impact of temperature and methylene blue pathogen inactivation.Role of Riboflavin- and UV Light-Treated Plasma in Prevention of Transfusion-Related Acute Lung Injury.Component pathogen inactivation: a critical review.A comparison of methods of pathogen inactivation of FFP.Update on the use of pathogen-reduced human plasma and platelet concentrates.Coagulation factor content of plasma produced from whole blood stored for 24 hours at ambient temperature: results from an international multicenter BEST Collaborative study.Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusion.Guidelines on transfusion for fetuses, neonates and older children.
P2860
Q26741073-C9E76D4D-3EF8-4F69-9A12-5C26C3D5B9EBQ26996247-9B5450DD-8DDB-44A2-B417-C1A4F92216DAQ33396311-20BF86D0-E727-4020-A996-79D92B4CF888Q33401173-054135DE-EA84-4700-B65C-973976DE205BQ33401403-0D51063F-ECD7-489D-8B1F-17300AAD9A65Q33424405-0F8F3222-8709-4785-9C70-70D05D5F0C3EQ33453947-F2301BAE-5FAB-470F-9A2F-05D3ED610FCDQ33863382-D01369DF-778F-45E3-8C95-4F3DCDFB8204Q34310415-80D77D6C-A21B-4D35-9ED0-73E3D2C2D896Q37776318-8416437E-60A9-4F7A-AEDA-FA0036A8F50BQ38109665-BD4AA68B-9B65-4BDF-84D6-51C91AB715C6Q43744630-538E47EC-A286-413F-8C71-443A82B872B7Q46141738-FD89C270-8221-443C-B8A8-84AFAFC3D9A0Q53674609-51FC3FA1-E94E-43C3-933E-57D659B8C7D9
P2860
Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort study.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Methylene blue-photoinactivate ...... ric, prospective cohort study.
@ast
Methylene blue-photoinactivate ...... ric, prospective cohort study.
@en
type
label
Methylene blue-photoinactivate ...... ric, prospective cohort study.
@ast
Methylene blue-photoinactivate ...... ric, prospective cohort study.
@en
prefLabel
Methylene blue-photoinactivate ...... ric, prospective cohort study.
@ast
Methylene blue-photoinactivate ...... ric, prospective cohort study.
@en
P2093
P2860
P1476
Methylene blue-photoinactivate ...... tric, prospective cohort study
@en
P2093
Adrián Alegre
Alberto Alvarez-Larrán
Arturo Pereira
Aurora Viejo
Clara Martínez
Concepción Zamora
Consuelo Ramírez
Cristina Arbona
Dolors Castellà
Enric Contreras
P2860
P356
10.1111/J.1365-2141.2008.07292.X
P407
P577
2008-07-14T00:00:00Z